Literature DB >> 25362116

Understanding the impact of physical activity in COPD outcomes: moving forward.

Richard ZuWallack1, Cristóbal Esteban2.   

Abstract

Mesh：

Year:  2014        PMID： 25362116     DOI： 10.1183/09031936.00151014

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting.

Authors:  Karl-Otto Steinmetz; Birgit Abenhardt; Stefan Pabst; Michaela Hänsel; Anke Kondla; Valentina Bayer; Roland Buhl
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-04

2.  Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease.

Authors:  Seong Mi Moon; Jun Hyeok Lim; Yun Soo Hong; Kyeong-Cheol Shin; Chang Youl Lee; Do Jin Kim; Sang Haak Lee; Ki Suck Jung; Chang-Hoon Lee; Kwang Ha Yoo; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 3.005

Review 3.  Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses.

Authors:  François Maltais; Alberto de la Hoz; Richard Casaburi; Denis O'Donnell
Journal:  Adv Ther       Date:  2020-12-11       Impact factor: 3.845

4.  Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment.

Authors:  Marc Spielmanns; Sebastian Schildge; Jens Peter Diedrich; Arschang Valipour
Journal:  Clin Pract       Date:  2022-01-07

5.  High 24-Hour Respiratory Symptoms and Low Physical Activity in the Stable COPD Romanian Cohort of SPACE Study.

Authors:  Florin Mihaltan; Ruxandra-Mioara Rajnoveanu; Oana Cristina Arghir; Silviu Alecu; Paraschiva A Postolache
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-09-06

6.  Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design.

Authors:  Thierry Troosters; Jean Bourbeau; François Maltais; Nancy Leidy; Damijan Erzen; Dorothy De Sousa; Lawrence Korducki; Alan Hamilton
Journal:  BMJ Open       Date:  2016-04-13       Impact factor: 2.692

7.  Pulmonary rehabilitation: Recommended but not implemented.

Authors:  Sibel Günay; Muzaffer Sariaydin
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.